• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Checkpoint Therapeutics Inc (NQ: CKPT )

    2.221 -0.099 (-4.26%)
    Streaming Delayed Price Updated: 12:10 PM EDT, Aug 20, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 140,958
    Open 2.300
    Bid (Size) 2.220 (20)
    Ask (Size) 2.240 (2)
    Prev. Close 2.320
    Today's Range 2.215 - 2.320
    52wk Range 1.300 - 3.620
    Shares Outstanding 41,631,500
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    CKPT Stock Earnings: Checkpoint Therapeutics Beats EPS, Beats Revenue for Q2 2024
    CKPT stock results show that Checkpoint Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
    Via InvestorPlace
    CHECKPOINT ALERT: Bragar Eagel & Squire, P.C. is Investigating Checkpoint Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire

    Performance

    YTD
    +1.42%
    +1.42%
    1 Month
    -10.80%
    -10.80%
    3 Month
    +9.42%
    +9.42%
    6 Month
    +12.18%
    +12.18%
    1 Year
    -3.84%
    -3.84%

    More News

    Read More
    CKPT DEADLINE TODAY: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Before Important June 4 Deadline in Securities Class Action - CKPT
    Via NewMediaWire
    Topics Lawsuit
    Exposures Financial Legal
    CKPT DEADLINE TODAY: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Before Important June 4 Deadline in Securities Class Action - CKPT
    Via TheNewswire.com
    Topics Lawsuit
    Exposures Financial Legal
    DEADLINE TODAY: The Schall Law Firm Encourages Investors in Checkpoint Therapeutics, Inc. with Losses to Contact the Firm
    From Schall Law
    Via GlobeNewswire
    The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Checkpoint Therapeutics, Inc. (CKPT)
    From The Law Offices of Frank R. Cruz
    Via Business Wire
    CKPT FINAL DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Before Important June 4 Deadline in Securities Class Action - CKPT
    Via NewMediaWire
    Topics Lawsuit
    Exposures Financial Legal
    CKPT FINAL DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Before Important June 4 Deadline in Securities Class Action - CKPT
    Via TheNewswire.com
    Topics Lawsuit
    Exposures Financial Legal
    INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Checkpoint
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    CHECKPOINT DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Checkpoint Therapeutics, Inc. and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    ROSEN, A LEADING LAW FIRM, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Before Important June 4 Deadline in Securities Class Action – CKPT
    From The Rosen Law Firm PA
    Via GlobeNewswire
    SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Checkpoint
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    7-DAY DEADLINE ALERT: The Schall Law Firm Encourages Investors in Checkpoint Therapeutics, Inc. with Losses to Contact the Firm
    From Schall Law
    Via GlobeNewswire
    ROSEN, NATIONAL TRIAL LAWYERS, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Before Important June 4 Deadline in Securities Class Action - CKPT
    Via NewMediaWire
    Topics Lawsuit
    Exposures Financial Legal
    ROSEN, NATIONAL TRIAL LAWYERS, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Before Important June 4 Deadline in Securities Class Action - CKPT
    Via TheNewswire.com
    Topics Lawsuit
    Exposures Financial Legal
    CKPT SHAREHOLDER ALERT: TOP RANKED ROSEN LAW FIRM Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Before Important June 4 Deadline in Securities Class Action – CKPT
    From The Rosen Law Firm PA
    Via GlobeNewswire
    SHAREHOLDER ALERT Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Checkpoint
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    June 4th Lead Plaintiff Deadline Approaching in Class Action Against Checkpoint Therapeutics, Inc. – Contact Robbins LLP Today
    From Robbins LLP
    Via GlobeNewswire
    INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Checkpoint Therapeutics, Inc. with Losses to Contact the Firm
    From Schall Law
    Via GlobeNewswire
    ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CKPT
    Via NewMediaWire
    Topics Lawsuit
    Exposures Financial Legal
    ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CKPT
    Via TheNewswire.com
    Topics Lawsuit
    Exposures Financial Legal
    ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CKPT
    Via NewMediaWire
    Topics Lawsuit
    Exposures Financial Legal
    ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CKPT
    Via TheNewswire.com
    Topics Lawsuit
    Exposures Financial Legal
    Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against HireRight, Checkpoint, Ocugen, and Sonder Innovations and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Checkpoint
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.